Streetbeat News

Products Services

OGEN

Oragenics has announced that its product ONP-002 has a potential addressable market opportunity that includes an estimated 69 million concussions globally.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:30 pm

OGEN

Oragenics announced that its concussion drug, ONP-002, has successfully cleared FDA-required cardiotoxicity testing. This is a significant milestone for the company as it progresses in the development of this drug.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:30 pm

HCAT

Health Catalyst, Inc. (NASDAQ:HCAT) has announced an expanded partnership with Contexture to include technology and services support for Quality Health Network. Contexture is a nonprofit organization that facilitates health data interoperability in Arizona and Colorado.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:29 pm

APLS

Apellis Pharmaceuticals shares are trading higher following the announcement of positive topline results from the Phase 3 VALIANT study on systemic pegcetacoplan for treating C3 glomerulopathy and primary immune complex membranoproliferative glomerulonephritis.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:29 pm

LLY

Eli Lilly (NYSE: LLY) reported strong Q2 earnings, with revenue of $11.3 billion, up 36% YoY, surpassing estimates. The growth was driven by increased sales of diabetes and weight loss drugs, particularly Mounjaro, Zepbound, Verzenio, Taltz, and Jardiance. The company raised its 2024 sales and EPS guidance, reflecting confidence in continued strong performance.

Portfolio Pulse from Vandana Singh

August 08, 2024 | 12:26 pm

AIPI

DAT

MSFT

PLTR

Palantir Technologies Inc. (NYSE:PLTR) shares are trading higher after announcing a partnership with Microsoft Corporation (NASDAQ:MSFT) to enhance analytics and AI services for U.S. Defense and Intelligence. The deal integrates Microsoft's Large Language Models with Palantir's AI Platform within Microsoft's government cloud environments. PLTR stock has gained over 54% in the past year. Investors can also gain exposure via REX AI Equity Premium Income ETF (NASDAQ:AIPI) and ProShares Big Data Refiners ETF (NYSE:DAT).

Portfolio Pulse from Nabaparna Bhattacharya

August 08, 2024 | 12:24 pm

GENI

Genius Sports Limited (NYSE: GENI) has launched GeniusIQ, a next-generation sports data and AI platform aimed at revolutionizing sports analysis, fan engagement, advertising, and sports betting. The platform leverages machine learning and generative AI to provide advanced game analysis and immersive experiences for sports fans.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:24 pm

PDSB

PDS Biotechnology Corporation (NASDAQ:PDSB) announced that updated data from its IMMUNOCERV Phase 2 clinical trial will be presented at the 2024 ASTRO Annual Meeting. The trial evaluates Versamune HPV with chemoradiation for treating locally advanced cervical cancer.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:22 pm

KPLT

Katapult Holdings, Inc. (NASDAQ:KPLT) has been selected by Meineke, a leading automotive repair chain, to be part of its consumer application process, Meineke Payment Solutions. This partnership is endorsed by the Meineke Dealers Association and involves Premier Services Group and FormPiper.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:20 pm

MGRM

Monogram Technologies Inc. (NASDAQ:MGRM) has submitted a 510(k) premarket filing to the FDA for its mBôs TKA System. The application, submitted on July 19, 2024, has passed the FDA Administrative Review and is now under substantive review. A decision is expected within 90 days, though the process may be paused if additional information is requested.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2024 | 12:11 pm